Trailing-twelve-month (TTM) revenue is $6.69 Billion with a year-over-year growth of +15.30%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $1,773,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q3 FY2026Period ended 2025-12-31 | $1,699,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-04 |
| Q4 FY2026Period ended 2026-03-31 | $1,679,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-22 |
| Q1 FY2027Period ended 2026-06-30 | $1,533,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $6,686,500,000 |
Current P/S: $40,563,441,200 market capitalization ÷ $6,686,500,000 TTM revenue = 6.07x.
Market capitalization source: FMP quote. Quote observed 2026-09-15T14:05:19.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $1.53B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-15T14:07:03.234Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Console | $2.5B | $2.5B | $2.3B | $2.2B | $2.1B | $2.6B |
| Mobile | N/A | $403M | $2.5B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $1.4B | $1.4B | $2.0B | $2.1B | $2.2B | $2.7B |
| UNITED STATES | $2.0B | $2.1B | $3.4B | $3.3B |
$6.69B
$6.69 Billion
+15.30%
vs. $5.80B a year ago (TTM)
+14.79%
5 Year compound annual growth rate
1 Year
+15.30%
3 Year
+6.52%
5 Year
+14.79%
10 Year
+16.52%
15 Year
+12.10%
20 Year
+9.84%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $6.66B | +$1.02B | +18.16% |
| 2025 | $5.63B | +$284.00M | +5.31% |
| 2024 | $5.35B | ($300,000) | (0.01%) |
| 2023 | $5.35B | +$1.85B | +52.64% |
| 2022 | $3.50B | +$132.00M | +3.91% |
| 2021 |
TTM Growth
+15.30%
3-Year CAGR
+6.52%
5-Year CAGR
+14.79%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-15T14:07:03.234Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.9B |
| $3.3B |
| P C And Other Products | $856M | $573M | $508M | $434M | $593M | $726M |
|---|
| $3.9B |
| $3.37B |
| +$283.83M |
| +9.19% |
| 2020 | $3.09B | +$420.58M | +15.76% |
| 2019 | $2.67B | +$875.50M | +48.83% |
| 2018 | $1.79B | +$13.14M | +0.74% |
| 2017 | $1.78B | +$366.05M | +25.89% |
